MedTrace Logo

AVODART® Alopecia Post-marketing Surveillance (PMS)

NCT01004809 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 712

Last updated 2018-06-19

No results posted yet for this study

Summary

Post-marketing surveillance(PMS) to monitor the safety and effectiveness of dutasteride in Korean androgenetic alopecia patients

Conditions

Interventions

DRUG

Dutasteride

Basically there is no treatment allocation. Subjects who would be administered of dutasteride at their physicians' discretion will be enrolled. Dosage regimen will be recommended according to the prescribing information. Subjects will be enrolled consecutively.

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Min Age
18 Years
Max Age
41 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-29
Primary Completion
2012-12-01
Completion
2012-12-21

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01004809 on ClinicalTrials.gov